Newsroom Bayer

December
07,
2023
| 08:29 AM Europe/Amsterdam
London, UK, and Basel, Switzerland, December 7, 2023 – Salus Optima, a leading provider in AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a strategic partnership to empower people on their
December
04,
2023
| 07:59 AM Europe/Amsterdam
Silal, and Bayer, a global leader in life sciences, have partnered to strengthen the agricultural landscape in the UAE / The partnership will focus on implementing best-in-class agricultural practices, capacity building programs as well as
November
30,
2023
| 13:59 PM Europe/Amsterdam
Development and option to license agreement allows single-handed inserter to be developed and combined with Bayer’s leading hormonal intrauterine systems (IUSs) / New inserter has the potential to improve intrauterine placement / Deal further
November
28,
2023
| 08:29 AM Europe/Amsterdam
Advancing precision health and accelerating access to novel epigenetic and multi-omics at-home biomarker tests to empower consumers on their aging journey
November
23,
2023
| 13:14 PM Europe/Amsterdam
Investment part of billion-dollar investment program / Commitment to Berlin as an innovation hub / Governing Mayor of Berlin, Kai Wegner, inaugurates new facility together with Bayer Board Member Stefan Oelrich / New facility equipped with
November
22,
2023
| 13:59 PM Europe/Amsterdam

Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation

Not intended for U.S. and UK Media – Radiological Society of North America (RSNA) 2023 Annual Meeting

First presentation of Phase II data for the development compound gadoquatrane, Bayer’s investigational MRI contrast agent, at RSNA 2023 / Publication of a novel health economic model, analyzing cost effectiveness and capacity needs of supplemental
November
19,
2023
| 23:48 PM Europe/Amsterdam

OCEANIC-AF study stopped early due to lack of efficacy

Not intended for U.S. and UK Media

Independent Data Monitoring Committee (IDMC) recommends stopping the OCEANIC-AF study due to an inferior efficacy of asundexian versus the control arm  / OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial
November
17,
2023
| 13:59 PM Europe/Amsterdam
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels in the brain for the treatment of MSA-P / Phase 1 randomized, controlled trial to assess safety of AB-1005 delivered to the putamen in
November
17,
2023
| 07:29 AM Europe/Amsterdam

Bayer places new bonds with a volume of 5.75 billion U.S. dollars

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Leverkusen, November 17, 2023 – On Thursday, the Bayer Group successfully placed bonds with a volume of 5.75 billion U.S. dollars, which will be issued by its subsidiary Bayer US Finance LLC, St. Louis, United States, and guaranteed by Bayer AG. The
November
13,
2023
| 11:29 AM Europe/Amsterdam
Professor Claudia Höbartner from the Institute of Organic Chemistry at the University of Würzburg, Germany receives this year’s Hansen Family Award for her pioneering research in biomolecular chemistry of functional nucleic acids / Four young
November
13,
2023
| 08:59 AM Europe/Amsterdam
New connectors allow secure, compliant data exchange / Industry platform Microsoft Azure Data Manager expands as more companies bring solutions: Leaf Agriculture further enhances useability of farm machinery data and OneSoil powers in-season

Sign up for our Newsletter

We will keep you informed about the latest news.